Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8AQF

CRYSTAL STRUCTURE OF HUMAN MONOGLYCERIDE LIPASE WITH COMPOUND LEI-515

Summary for 8AQF
Entry DOI10.2210/pdb8aqf/pdb
DescriptorMonoglyceride lipase, 1-[(~{R})-[2-chloranyl-4-[(2~{S},3~{S})-4-(3-chlorophenyl)-2,3-dimethyl-piperazin-1-yl]carbonyl-phenyl]sulfinyl]-3,3-bis(fluoranyl)pentan-2-one (3 entities in total)
Functional Keywordsmonoacylglycerol lipase, magl, inhibitor, hydrolase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight35996.96
Authors
Primary citationJiang, M.,Huizenga, M.C.W.,Wirt, J.L.,Paloczi, J.,Amedi, A.,van den Berg, R.J.B.H.N.,Benz, J.,Collin, L.,Deng, H.,Di, X.,Driever, W.F.,Florea, B.I.,Grether, U.,Janssen, A.P.A.,Hankemeier, T.,Heitman, L.H.,Lam, T.W.,Mohr, F.,Pavlovic, A.,Ruf, I.,van den Hurk, H.,Stevens, A.F.,van der Vliet, D.,van der Wel, T.,Wittwer, M.B.,van Boeckel, C.A.A.,Pacher, P.,Hohmann, A.G.,van der Stelt, M.
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence.
Nat Commun, 14:8039-8039, 2023
Cited by
PubMed Abstract: Monoacylglycerol lipase (MAGL) regulates endocannabinoid 2-arachidonoylglycerol (2-AG) and eicosanoid signalling. MAGL inhibition provides therapeutic opportunities but clinical potential is limited by central nervous system (CNS)-mediated side effects. Here, we report the discovery of LEI-515, a peripherally restricted, reversible MAGL inhibitor, using high throughput screening and a medicinal chemistry programme. LEI-515 increased 2-AG levels in peripheral organs, but not mouse brain. LEI-515 attenuated liver necrosis, oxidative stress and inflammation in a CCl-induced acute liver injury model. LEI-515 suppressed chemotherapy-induced neuropathic nociception in mice without inducing cardinal signs of CB activation. Antinociceptive efficacy of LEI-515 was blocked by CB, but not CB, antagonists. The CB antagonist rimonabant precipitated signs of physical dependence in mice treated chronically with a global MAGL inhibitor (JZL184), and an orthosteric cannabinoid agonist (WIN55,212-2), but not with LEI-515. Our data support targeting peripheral MAGL as a promising therapeutic strategy for developing safe and effective anti-inflammatory and analgesic agents.
PubMed: 38052772
DOI: 10.1038/s41467-023-43606-3
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.55 Å)
Structure validation

247947

PDB entries from 2026-01-21

PDB statisticsPDBj update infoContact PDBjnumon